Skip to main content
Premium Trial:

Request an Annual Quote

Ariosa Inks Deal to Offer Fetal Trisomy Test in UK

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said it is partnering with The Fetal Medicine Centre to offer its Harmony Prenatal Test in the UK.

San Jose, Calif.-based Ariosa launched the test for non-invasive detection of fetal trisomies in the US and Canada in May under an agreement with Laboratory Corporation of America, and today's agreement makes The Fetal Medicine Centre the first institution to offer the Harmony test outside of North America. Patients may now see a healthcare provider at the Fetal Medicine Centre, located in London, and receive counseling for the test, said Ariosa.

Financial and other terms of the deal were not disclosed.

The test uses sequencing technology for the analysis of cell-free DNA from a maternal blood draw to detect for common fetal trisomies, such as Trisomy 21.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.